Molecular Partners AG
MOLNHealthcare|Biotechnology|CH
$3.14
-0.08 (-2.48%)
DCF Value
$2.61
Tangible Book / Share
$1.32
Cash / Share
$1.50
Ownership Breakdown
99.7%
Float
38.3M
Shares Outstanding
38.2M
Float Shares
Major Holders (4)
Combined: 37.6%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Aaron Cowen | HC, IN | 10.60% | 4,284,806 | May 2, 2025 | 13D/G |
| Averill Master Fund, Ltd. | Corporation | 10.60% | 4,284,806 | May 2, 2025 | 13D/G |
| Suvretta Capital Management, LLC | IA, OO | 10.60% | 4,284,806 | May 2, 2025 | 13D/G |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | Holding company | 5.80% | 2,144,607 | Jul 17, 2025 | 13D/G |